Search results
Market Today: Pfizer Pauses Gene Therapy Trial After Patient Dea
Guru Focus· 3 hours agoThe stock market exhibited mixed results at the close today. The Nasdaq Composite edged down by...
AstraZeneca pulls Covid vaccine after admitting rare side effect
Daily Express· 2 hours agoThe Oxford-AstraZeneca Covid vaccine is set to be withdrawn after the pharmaceutical giant admitted...
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
CNBC· 10 hours agoThe injectable weight-loss medication Wegovy is available at New City Halstead Pharmacy on April 24,...
Pfizer (PFE) Q1 Earnings and Revenues Beat Estimates
Zacks via Yahoo Finance· 7 days agoPfizer (PFE) delivered earnings and revenue surprises of 46.43% and 7.37%, respectively, for the quarter ended March 2024. Do the numbers hold clues to...
Leerink Partnrs Comments on Pfizer Inc.’s Q2 2024 Earnings (NYSE:PFE)
ETF DAILY NEWS· 23 hours agoPfizer Inc. (NYSE:PFE – Free Report) – Stock analysts at Leerink Partnrs upped their Q2 2024 earnings estimates for Pfizer in a report issued on Thursday ...
Pfizer Is Adding a Wall Street Analyst to Its C-Suite. What He Thinks the Company Needs to Do.
Barrons.com· 1 day agoSTOCK ALERT Andrew Baum, the prominent Wall Street drug company analyst, has never been much of a...
Pfizer hires Citi healthcare analyst Baum to lead strategy and innovation
Seeking Alpha· 1 day agoPfizer appoints Andrew Baum from Citi as chief strategy and innovation officer, responsible for...
Pfizer reports patient death in Duchenne gene therapy study
Reuters· 5 hours ago, opens new tab experimental gene therapy for a muscle-wasting disorder called Duchenne muscular...
Cramer explains how to maintain a 'balanced' portfolio as the economy slows
CNBC· 3 hours agoCNBC's Jim Cramer on Tuesday said Wall Street is currently going through a tricky stage of the...
Pfizer's Options Frenzy: What You Need to Know - Pfizer (NYSE:PFE)
Benzinga· 1 day agoLoading... Loading... Deep-pocketed investors have adopted a bullish approach towards Pfizer PFE , and it's something market players shouldn't ignore. Our tracking of public ...